Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion.

Finnegan CM, Rawat SS, Cho EH, Guiffre DL, Lockett S, Merrill AH Jr, Blumenthal R.

J Virol. 2007 May;81(10):5294-304. Epub 2007 Mar 7.

2.

Effect of cholesterol on lateral diffusion of fluorescent lipid probes in native hippocampal membranes.

Pucadyil TJ, Chattopadhyay A.

Chem Phys Lipids. 2006 Sep;143(1-2):11-21. Epub 2006 May 7.

PMID:
16797513
3.

Cellular entry of HIV: Evaluation of therapeutic targets.

Pöhlmann S, Reeves JD.

Curr Pharm Des. 2006;12(16):1963-73. Review.

PMID:
16787241
4.

Sphingolipids, cholesterol, and HIV-1: a paradigm in viral fusion.

Rawat SS, Viard M, Gallo SA, Blumenthal R, Puri A.

Glycoconj J. 2006 May;23(3-4):189-97.

PMID:
16691502
5.

Sphingolipids: modulators of HIV-1 infection and pathogenesis.

Rawat SS, Johnson BT, Puri A.

Biosci Rep. 2005 Oct-Dec;25(5-6):329-43. Review.

PMID:
16307380
6.

Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.

Wyss S, Dimitrov AS, Baribaud F, Edwards TG, Blumenthal R, Hoxie JA.

J Virol. 2005 Oct;79(19):12231-41.

7.

Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement.

Nguyen DH, Giri B, Collins G, Taub DD.

Exp Cell Res. 2005 Apr 1;304(2):559-69. Epub 2004 Dec 23.

PMID:
15748900
8.

Ceramide, a target for antiretroviral therapy.

Finnegan CM, Rawat SS, Puri A, Wang JM, Ruscetti FW, Blumenthal R.

Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15452-7. Epub 2004 Oct 15.

9.

The role of lipid microdomains in virus biology.

Nayak DP, Hui EK.

Subcell Biochem. 2004;37:443-91. Review.

PMID:
15376630
12.

Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion.

Rawat SS, Gallo SA, Eaton J, Martin TD, Ablan S, KewalRamani VN, Wang JM, Blumenthal R, Puri A.

J Virol. 2004 Jul;78(14):7360-8.

14.

Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion.

Rawat SS, Eaton J, Gallo SA, Martin TD, Ablan S, Ratnayake S, Viard M, KewalRamani VN, Wang JM, Blumenthal R, Puri A.

Virology. 2004 Jan 5;318(1):55-65.

15.
16.

The HIV Env-mediated fusion reaction.

Gallo SA, Finnegan CM, Viard M, Raviv Y, Dimitrov A, Rawat SS, Puri A, Durell S, Blumenthal R.

Biochim Biophys Acta. 2003 Jul 11;1614(1):36-50. Review.

17.

Localization of CD4 and CCR5 in living cells.

Steffens CM, Hope TJ.

J Virol. 2003 Apr;77(8):4985-91.

18.

The roles of membrane microdomains (rafts) in T cell activation.

Horejsí V.

Immunol Rev. 2003 Feb;191:148-64. Review.

PMID:
12614358
19.

HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains.

Percherancier Y, Lagane B, Planchenault T, Staropoli I, Altmeyer R, Virelizier JL, Arenzana-Seisdedos F, Hoessli DC, Bachelerie F.

J Biol Chem. 2003 Jan 31;278(5):3153-61. Epub 2002 Nov 12.

20.

Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells.

Viard M, Parolini I, Sargiacomo M, Fecchi K, Ramoni C, Ablan S, Ruscetti FW, Wang JM, Blumenthal R.

J Virol. 2002 Nov;76(22):11584-95.

Items per page

Supplemental Content

Write to the Help Desk